Evotec AG has signed an agreement on a four-year research collaboration with Pfizer Inc. in the field of tissue fibrosis. Under the terms of this license and collaboration agreement, scientists at Evotec and Pfizer will explore potential novel mechanisms as targeted anti-fibrotics in multi-organ fibrosis. Evotec will contribute its drug discovery platform whereas Pfizer will provide key technologies and industrial scope as well as pharmaceutical development and marketing expertise. Financi...